How to confirm a diagnosis of leptospirosis affecting the central nervous system (CNS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Leptospirosis with CNS Involvement

To confirm a diagnosis of leptospirosis affecting the central nervous system (CNS), a combination of clinical features, serological testing, and CSF analysis is required, with serological confirmation being the most definitive approach. 1

Clinical Presentation Suggestive of Neuroleptospirosis

  • Leptospirosis typically follows a biphasic course with an initial bacteremic phase with flu-like symptoms lasting 4-7 days, followed by an immune phase characterized by fever, myalgia, and potential organ involvement 1
  • CNS involvement occurs in approximately 10-15% of leptospirosis cases, with presentations ranging from aseptic meningitis to encephalitis 2
  • Key clinical features suggesting neuroleptospirosis include:
    • Fever with chills and rigors, headache, and vomiting 2
    • Altered sensorium (seen in up to 81% of neuroleptospirosis cases) 2
    • Conjunctival suffusion (redness without exudate) - a highly suggestive clinical sign 1, 3
    • Evidence of hepatorenal dysfunction (jaundice, elevated liver enzymes, renal impairment) 1, 2
    • History of exposure to contaminated water or animals, particularly in endemic areas 4, 5

Diagnostic Testing Algorithm

1. Initial Laboratory Investigations

  • Complete blood count (may show polymorphonuclear leukocytosis, thrombocytopenia, anemia) 1
  • Liver function tests (elevated bilirubin with mild elevation of transaminases) 1
  • Renal function tests (may show evidence of renal failure) 1
  • Urinalysis (may show proteinuria and hematuria) 1

2. Serological Testing (Most Important)

  • Collect blood for serological testing as early as possible 1, 3
  • IgM ELISA - earliest positives appear 6-10 days after symptom onset 1
    • An IgM titer >1:320 is considered suggestive of leptospirosis 1
    • A titer of 1:80 to 1:160 is consistent with early infection but may be due to cross-reactions 1
  • Microscopic Agglutination Test (MAT) - the gold standard for confirmation 1, 3
    • Collect convalescent serum >10 days after symptom onset 1
    • A fourfold or greater increase in titer between acute and convalescent specimens confirms the diagnosis 3
    • A single MAT titer ≥1:200 supports a probable case classification 3

3. CSF Analysis (Critical for CNS Involvement)

  • Perform lumbar puncture if no contraindications exist 1
  • Typical CSF findings in neuroleptospirosis:
    • Pleocytosis with lymphocytic predominance (mean 50 cells/μL) 2
    • Elevated protein levels (mean 115.5 ± 67.5 mg%) 2
    • Normal glucose 1
  • Send CSF for:
    • Leptospira antibody testing - positive in some cases of neuroleptospirosis 2
    • PCR for Leptospira - if available and within first 5 days of illness 1, 6
    • Other tests to exclude differential diagnoses (Gram stain, bacterial culture, viral PCRs) 1

4. Blood Culture

  • Collect aerobic blood cultures within the first 5 days of onset, before antibiotics 1
  • Keep blood cultures at room temperature prior to dispatch to reference laboratory 1
  • Note: Urine is not a suitable sample for isolation of leptospira 1

5. Neuroimaging

  • MRI is preferred over CT for evaluation of CNS infections 1
  • In neuroleptospirosis, neuroimaging may be normal in majority of cases (67%) 2
  • When abnormal, diffuse cerebral edema is the most common finding (26%) 2

Diagnostic Criteria for Confirmation

  • Confirmed case: A clinically compatible case with one of the following 3:

    • Isolation of Leptospira from a clinical specimen
    • Fourfold or greater increase in Leptospira agglutination titer between acute and convalescent serum specimens
    • Demonstration of Leptospira in clinical specimen by immunofluorescence
  • Probable case: A clinically compatible case with supportive serologic findings (Leptospira agglutination titer ≥200 in one or more serum specimens) 3

Important Considerations and Pitfalls

  • Deep altered sensorium at presentation and raised CSF protein are poor prognostic indicators 2
  • Pathological mechanisms in neuroleptospirosis include direct invasion, immune-mediated processes, and vasculitis 2, 7
  • Consider leptospirosis in patients with aseptic meningitis, especially with history of water exposure or animal contact 5
  • Treatment should be initiated upon clinical suspicion without waiting for laboratory confirmation, as early treatment improves outcomes 1, 3
  • Differential diagnosis should include other tropical infections that can cause CNS manifestations 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Leptospirosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Leptospirosis Transmission and Prevention in India

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and epidemiology of leptospirosis.

Medecine et maladies infectieuses, 2013

Research

Cerebellar ataxia due to Leptospirosis- a case report.

BMC infectious diseases, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.